Transnasal Humidified Rapid Insufflation System for Intubation

NCT ID: NCT04238351

Last Updated: 2020-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-25

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transnasal humidified rapid insufflation ventilator exchange (THRIVE) or not during the anesthesia induction

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Control group-usual mask ventilation during apnea for anesthetic intubation and check tube positioning THRIVE group-applying THRIVE during apnea for anesthetic intubation and check tube positioning

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoxemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Applying Transnasal humidified rapid insufflation ventilator exchange
Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors
Participants, care giver and outcome assessor can not know the group assingment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

usual mask ventilation during anethesia induction

Group Type EXPERIMENTAL

Conventional face mask

Intervention Type DEVICE

applying oxygen using usual face mask

THRIVE

Applying Transnasal humidified rapid insufflation ventilator exchange during anesthesia induction

Group Type ACTIVE_COMPARATOR

Transnasal humidified rapid insufflation ventilator exchange

Intervention Type DEVICE

applying 40L of oxygen for 1min and afte that increase oxygen flow up to 70L for 1 min.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transnasal humidified rapid insufflation ventilator exchange

applying 40L of oxygen for 1min and afte that increase oxygen flow up to 70L for 1 min.

Intervention Type DEVICE

Conventional face mask

applying oxygen using usual face mask

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who scheduled for elective lung surery with one lung ventilation

Exclusion Criteria

* suspicious difficult intubation (BMI \>35kg/m2, mouth opening \< 3 finger, Mallampati G \>3), Room air SpO2 \< 90%, active pulmonary infection, emergency operation, pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gachon University Gil Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Youn Yi Jo

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Gil2019-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nasal Ventilation vs Face Mask
NCT03853239 UNKNOWN NA